Impax Laboratories Inc. (IPXL)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q2 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 4,043,203 | 1.01 | |
| Q1 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 44.82% | 3,284,595 | 0.82 | |
| Q3 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 9.29% | 665,038 | 0.17 | |
| Q2 2016 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 154,561 | 0.98 | |
| Q3 2015 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 3.65% | 5,547 | 0.04 | |
| Q2 2015 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 43.21% | 115,577 | 0.85 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.